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SUMMARY
Setd2 is known as a histone-H3K36-specific methyl-
transferase. However, its role in physiological func-
tion remains unclear. In this study, we show that
Setd2 mainly regulates differentiation of murine em-
bryonic stem cells (mESCs) toward primitive endo-
derm. Furthermore, we show that downregulated
endoderm-related genes in Setd2/ mESCs are
associated with an aberrantly low level of Erk activity
and that enforced expression of Fgfr3 can rescue the
defective Erk pathway in Setd2/ mESCs. Interest-
ingly, the transcriptional initiation of Fgfr3 is directly
regulated through histone H3K36me3 modification
in its distal promoter region by Setd2. These results
indicate that Setd2 controls the primitive endoderm
differentiation of mESCs by regulating the Fgfr3-Erk
signaling.
INTRODUCTION
Embryonic stem cells (ESCs) are pluripotent cells with two key
properties: self-renewal and differentiation into all cell types.
Gene expression patterns can effectively distinguish the differ-
ences between lineage-committed cells and the pluripotent
cells. It therefore stands to reason that proteins involved in the
control of transcription in ESCsmight play important roles in line-
age commitment and differentiation of pluripotent cells (Rey-
nolds et al., 2012). A complex regulatory network of transcription
factors has been shown to play critical roles for the maintenance
of ESCs lineage commitment or pluripotency (Chen et al., 2008).
In addition, several studies have shown that epigenetic events
can also regulate ESCs pluripotency. Knockdown or knockout
of chromatin regulators such as Jarid2 andWdr5 not only abolish
self-renewal but also trigger multiple lineage differentiation of
ESCs (Ang et al., 2011; Bilodeau et al., 2009; Fazzio et al.,
2008; Gaspar-Maia et al., 2009; Li et al., 2012; Loh et al., 2007;
Peng et al., 2009; Shen et al., 2009; Xie et al., 2011; Yuan
et al., 2009).
Histone methylation is now recognized as one of the most
important and complex epigenetic modification mechanisms,
occurring mainly at gene promoter regions linked to both acti-
vated and repressed gene expression (Barski et al., 2007; Martin
and Zhang, 2005). In murine embryonic stem cells (mESCs),
nearly 80% of nucleosomes are trimethylated at K4 of histone
H3 (H3K4me3) in promoter regions. These permissive chromatin
regions endow ESCs with an open transcriptional state and pro-
vide themwithmore developmental plasticity (Efroni et al., 2008).
Furthermore, ‘‘bivalent chromatin’’ containing both H3K4me3
and H3K27me3 modifications has also been found in ESCs
and most of the genes with bivalent chromatin structure seem
to be involved in cell fate determination (Bernstein et al., 2006).
Disruption of H3K4me3 or H3K27me3 leads ESCs to inefficiently
differentiate into a neural lineage (Jiang et al., 2011; Pasini
et al., 2007). Although the enrichment pattern of H3K9me3 was
observed at telemere, satellite, and long terminal repeats (Mik-
kelsen et al., 2007), two groups reported that more euchromatic
genes contain H3K9me3-modified nucleosomes inmESCs (Bilo-
deau et al., 2009; Karimi et al., 2011) and disruption of H3K9me3
leads to reduction of stem cell capacity and induction of differen-
tiation (Bilodeau et al., 2009). Enrichment pattern of H3K36me3
seems to be quite different from that of other histone methyla-
tions, because it is usually observed at body regions of active
genes, especially at their 30 terminal regions (Mikkelsen
et al., 2007). However, the function of H3K36me3 methylation in
mESCs self-renewal and lineage-specific differentiation remains
obscure.
Set2 is the sole H3K36 histone methyltransferase in yeast
(Strahl et al., 2002), and it can interact with elongating RNA po-
lymerase II (RNA pol II). Mutation of Set2 results in an increased
sensitivity to 6-azauracil, a useful tool for identifying proteins
important for elongation. This suggests that Set2 is required
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Figure 1. Setd2 Is Required for mESCs Endoderm Differentiation
(A) Morphology of WT and Setd2/ embryonic bodies (EBs) after being suspension cultured without LIF for 3 (left) and 6 days (right). The scale bar represents
10 mm.
(B) Left: hematoxylin and eosin staining of d3 EBs after gelatin-attached culture for 3 days. Black dotted lines indicate EBs, and white dotted lines indicate
the boundary of cells growing around EBs. Right: quantification of the areas of the cells growing around EBs. Data are presented as means ± SEM (n = 24–27);
***p < 0.001. The scale bar represents 5 mm.
(C) Real-time PCR analysis of endoderm lineagemarkers expressed in d3, d6, and d9WT andSetd2/ EBs. Relative expression levels were presented by 2^ DDCt
(knockout-WT), similarly hereinafter.
(legend continued on next page)
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for transcription elongation (Li et al., 2002). During RNA-pol-II-
mediated transcription elongation, H3K36me3 can be recog-
nized by Rpd3s complex, causing suppression of intragenic
transcription initiation through restraining histone exchange
(Carrozza et al., 2005; Keogh et al., 2005; Venkatesh et al.,
2012). This pathway can also regulate infrequently transcribed
long genes for accurate transcription in yeast (Li et al., 2007).
The human ortholog of Set2 is SETD2/HYPB, which was orig-
inally isolated from CD34+ hematopoietic stem/progenitor cells
by our group (Mao et al., 1998). SETD2/HYPB also acts as an
H3K36 methyltransferase in vitro and interacts with RNA pol II
in human cells (Sun et al., 2005). Disruption of Setd2 in mice
results in vascular remodeling defects and H3K36me3 down-
regulation (Hu et al., 2010). H3K36me3 tends to mark exons,
especially alternative exons, rather than introns in mammalian
genomes (de Almeida et al., 2011; Kolasinska-Zwierz et al.,
2009). It has been suggested that Setd2 plays a role in alternative
splicing (Luco et al., 2010). Interestingly, recent work revealed
that human SETD2 is often mutated in clear cell renal cell carci-
noma (cRCC) (Dalgliesh et al., 2010; Duns et al., 2010) and acute
leukemia (Mar et al., 2014; Zhu et al., 2014), whereas some can-
cer cells lacking H3K36me3 display microsatellite instability and
an elevated spontaneous mutation frequency (Li et al., 2013).
Although some biochemical mechanisms of H3K36me3 and
Setd2 have been revealed, transcriptional regulation through
Setd2-catalyzed H3K36me3 modification in development and
normal cellular function, such as ESCs self-renewal and lineage
differentiation, is yet to be investigated.
RESULTS
Setd2 Deficiency Is Dispensable for Self-Renewal of
Mouse ESCs
We first set out to dissect whether Setd2 could play a role in
maintaining the self-renewal and differentiation properties of
ESCs. Several observations suggest that depletion of Setd2
does not affect mESCs self-renewal. First, Setd2/ mESCs
kept aggregated morphology typical of undifferentiated mESCs
with amicrostructure similar to wild-type (WT) (Setd2+/+) mESCs,
including cell chromatin and cell junction (Figure S1A). Second,
staining for typical ESC markers including alkaline phosphatase
(AP), Oct4, and Sox2 were similar between WT and Setd2/
mESCs (Figures S1B and S1C). Furthermore, the expression
levels of core pluripotency factors (Oct4, Nanog, and Tbx3),
as analyzed by real-time PCR, were not significantly affected
by disruption of Setd2 (Figure S1D). These data indicate that
Setd2 is dispensable for self-renewal of mESCs.
We next examined whether the differentiation capacity of
mESCs would be affected when Setd2 was deficient. mESCs
were induced to differentiate into embryo bodies (EBs) in
leukemia inhibitory factor (LIF)-free suspension culture. The
morphology of day (d) 3 and d6 Setd2/ EBs showed no
obvious differences from that of WT EBs (Figure 1A). We then
transferred single d3 suspension-cultured EBs on gelatin-coated
dish. After 3 days of culture, the rate of growth and migration of
Setd2/ cells was much lower than that of WT EBs (Figure 1B),
similar to the phenotype of Grb2-deficient EBs (Cheng et al.,
1998). These data demonstrate that Setd2 plays an important
role in mESC differentiation.
Setd2 Is Required for mESC Differentiation toward
Endoderm
Because Grb2 is required for ESC endoderm differentiation
(Cheng et al., 1998), we speculated that Setd2 might also play
a role in this process. We collected d3, d6, and d9 suspension-
cultured mouse EBs and measured the expression level of
lineage markers by real-time PCR. Major primitive and visceral
endoderm lineage markers, including Gata6, Gata4, Sox7,
Hnf1b, Dab2, Cubn, Sox17, and Afp, were dramatically downre-
gulated in Setd2/ EBs (Figures 1C and S2A). Immunostaining
of frozen section for Gata6 and Dab2 in d5 EBs revealed a lack
of spontaneous differentiation of Setd2/ EBs to endoderm, in
contrast toWT EBs (Figure 1D). Flow cytometry analysis showed
a decreased expression of Gata6 in d5 Setd2/ EBs (Fig-
ure S2B). However, pluripotent, trophectoderm, ectoderm, and
mesodermmarkers did not show any significant change (Figures
S2C–S2F). Given the obvious vessel-remodeling defects in
Setd2/ mouse embryo and yolk sac (YC) revealed by our pre-
vious work (Hu et al., 2010), we further evaluated the expression
level of vessel developmental markers. Neither endotheliocyte
Pecam1 (Cd31) nor smooth muscle cell (SMA, Sm22a, and
Desmin) markers showed significant difference (Figure S2G),
suggesting that Setd2 was not essential for mesoderm-derived
cell differentiation but could influence the function of some
mesoderm-derived tissue cells, such as endotheliocytes.
Following a protocol designed for neural differentiation of
mESC, we observed that both WT and Setd2/ mESCs could
differentiate into tubb3-positive neural cells and that the
morphology of both cell lines did not show any difference during
the entire process. However, compared with the WT mESCs,
deficiency of Setd2 decreased the number of neuroectodermal
cells significantly, indicating Setd2 might be required for cell
growth, but not differentiation of neuroectoderm (Figure S2H).
It was reported that retinoic acid (RA) could induce ESCs to
differentiate into endoderm and further differentiation could be
carried out in LIF-free adherent culture in the presence of RA
(Smith et al., 2010). Indeed, as compared with WT, the induction
of endoderm-associated genes (Gata6 and Cubn) was signifi-
cantly decreased in Setd2/ mESCs (Figure 1E).
In the standard cultured conditions with medium containing
LIF and serum (Williams et al., 1988), mESCs expressed not
only pluripotency-associated transcription factors but also low
levels of lineage markers such as Fgf5 and Hex, because the
heterogeneous population contains both functional ESCs and
early lineage-like ESCs such as endoderm-like ESCs (Canham
et al., 2010; Niwa et al., 2000). The endoderm-like ESCs play an
(D) Immunofluorescence analysis of Gata6 (top) and Dab2 (bottom) expressed in d6 WT and Setd2/ EBs. The scale bar represents 10 mm.
(E) Real-time PCR analysis of endoderm-specific genes during RA-induced endoderm differentiation of WT and Setd2/ mESCs.
(F) Real-time PCR detection of basic expression level of endoderm, mesoderm, ectoderm, and trophectoderm lineage genes in WT and Setd2/ mESCs.
In (C), (E), and (F), means ± SD from at least triplicate measurements are shown. *p < 0.05; **p < 0.01; ***p < 0.001.
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important role in determining the fate of subsequent endoderm
differentiation (Canham et al., 2010). Having established the
importance of Setd2 in regulating endoderm differentiation, we
next asked whether the defects in Setd2/mESCs occurred af-
ter the initiation of differentiation or due to the influence on the
basal gene expression inmESCs. As comparedwithWTmESCs,
the expression level of many endoderm-related genes, but not
other lineage markers, were downregulated in Setd2/ mESCs
(Figure 1F). To further verify this phenotype, a humanSETD2 frag-
ment (503–2,564 amino acid [aa]), which contains the major
domain of SETD2 gene, was transfected into Setd2/ mESCs
(Figure 2A). As expected, increased level of H3K36me3 was
observed in SETD2-transfected Setd2/ mESCs, and the
expression levels of Gata6 and Sox7, but not T and Fgf5, were
Figure 2. Enforced Expression of Human SETD2 Can Rescue Endoderm Defects in Setd2/ mESCs
(A) RT-PCR detection of human SETD2 fragment (503–2,564 aa), 6set (SETD2 fragment with set domain deletion) expression (top) in SETD2-transfected
Setd2/ mESCs. Gapdh (bottom) was used as an internal control for RT-PCR.
(B) Immunoblotting analysis of histone H3K36me3 (top) and H3 (bottom) in SETD2-transfected Setd2/ and WT mESCs.
(C and D) Real-time PCR analysis of endoderm-specific genes inSETD2-transfected Setd2/mESCs and d5 EBs.Means ±SD from triplicatemeasurements are
shown. **p < 0.01; ***p < 0.001.
(E) Left: morphology of d3 SETD2-transfected Setd2/ EBs after gelatin-attached culture for 3 days. Right: quantification of the areas of the cells growing around
EBs. Data are presented as means ± SEM (n = 21–28); ***p < 0.001. GFP vector was used as a control for transfection. The scale bar represents 10 mm.
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augmented as well (Figures 2B and 2C). Moreover, the abnormal
expression of endoderm lineage marker, as well as the growth
and migration defects in Setd2/ EB cells could be rescued by
enforced SETD2 expression. In order to verify that Setd2-depen-
dent H3K36me3 is required for the expression of endoderm-
related genes and the phenotype of EBs, set-domain-deleted
SETD2 (6set) was transfected into Setd2/ mESCs. As
compared with WT SETD2, 6set showed much less-effective
rescue for the phenotype of Setd2/ mESCs, although some
slight migration increase was observed, which might be due to
the overexpression of other domains (Figures 2D and 2E). These
data indicate that Setd2-dependent H3K36me3 principally
regulates endoderm-specific basal gene expression in mESCs
and induces subsequent differentiation of endoderm.
Setd2 Is Required for Endoderm Development In Vivo
Although Setd2 could specifically regulate endoderm develop-
ment in vitro, it was still not clear whether it could regulate endo-
derm development in vivo. To address this, we subcutaneously
injectedmESCs into nonobese diabetic (NOD)-severe combined
immunodeficiency (SCID) mice as a standard assay to test the
potential of teratoma formation. Both WT and Setd2/ cells
could form tumors in 4 weeks (Figure 3A), but the tumors in
Setd2/ mESCs injected mice were much smaller than those
with WT ones (Figures 3B and 3C). Histology analysis showed
that bothWT and Setd2/mESCswere differentiated into ecto-
derm-derived nervous-like tissue and mesoderm-derived mus-
cle/adipocyte tissues, respectively (Figure 3D, left and middle).
All WT teratomas (4/4) formed normal intestinal epithelium tissue
derived from endoderm, whereas only two out of four Setd2/
teratomas gave rise to much smaller intestinal epithelium tissue
(Figure 3D, right). Morphological analysis of embryonic day 10
(E10) WT and Setd2/ YCs, mainly consisting of visceral endo-
derm and mesoderm, showed a disorganized phenotype and
loss of classic columnar epithelial morphology of visceral endo-
derm in Setd2/YCs (Figure 3E). Functional annotation analysis
of differentially expressed genes betweenWT and Setd2/ YCs
revealed that upregulated genes were highly enriched for those
associated with ‘‘cytoskeletal protein binding’’ (Figure 3F).
Real-time PCR validated the differential expression patterns of
a panel of genes encoding these proteins, including both up-
and downregulated genes (Figure 3G). F-actin staining revealed
no apical F-actin in YC visceral endoderm, whereas residual
F-actin was maintained in some tight junctions (Figure 3H).
Taken together, these data demonstrate that Setd2 is crucial
for the maintenance of normal visceral endoderm morphology
in vivo and might also influence its epithelial cell polarity.
Setd2 Regulates Endoderm Development through the
Fgfs-Fgfrs-Mek-Erk Signaling Pathway
In order to understand how Setd2 regulates endoderm differen-
tiation, RNA sequencing (RNA-seq) experiments were per-
formed to compare potential differences in gene expression
levels betweenWT andSetd2/mESCs. Several interesting ob-
servations were made. First, although most highly transcribed
genes showed no differences at transcriptional expression
levels, a number of infrequently transcribed genes exhibited
distinct expression patterns between WT and Setd2/ mESCs
(Figures S3A and S3B), a phenomena similar to what was
described in yeast (Li et al., 2007). Second, in accordance with
the recent report of SETD2 in human cell line (Carvalho et al.,
2013), deregulation of intragenic transcriptional initiation was
observed in 692 genes as compared with WT mESCs according
to Carvalho’s criteria (Table S1). Third, although distinct alterna-
tive splicing pattern was found in 157 genes in Setd2/ mESCs
(Figure S4; Table S2), consistent with the previous report (Luco
et al., 2010), scrutiny of these genes did not reveal specific clues
to the endoderm development defect. Last, but not least, by
gene ontology (GO) and Kyoto Encyclopedia of Genes and
Genomes (KEGG) pathway analyses (Figures S3C and S3D),
we noticed that among 2,516 genes appeared to be deregulated
in Setd2/ mESCs (Figure 4A; Table S3) and a subset of down-
regulated genes are related to the mitogen-activated protein
kinase (MAPK) signaling pathway (Figures 4B and S3E). It should
be pointed out that many MAPK-pathway-linked genes such as
Grb2 and Stk40 have been associated with endoderm differenti-
ation (Hamazaki et al., 2006; Li et al., 2010), suggesting that this
pathway might also be involved in the regulation of endoderm
development mediated by Setd2.
Because there are many different MAPK kinases that can be
activated by different signals (Figure 4C, left), we performed
western blots to determine the differences in expression levels
of the MAPK kinases between WT and Setd2/ mESCs. As
shown in Figure 4C (right panel), phosphorylated (p)-Erk was
downregulated, whereas other kinases appeared to be normal.
It has been shown that the activation of Erk mainly depends on
fibroblast growth factors (Fgfs) in mESCs (Kunath et al., 2007).
Based on this, we cultured WT and Setd2/ mESCs in starva-
tion condition for 12 hr, followed by Fgf2 and Fgf4 stimulation.
The Erk signaling pathway was significantly reduced in Setd2/
mESCs, as compared with that in WT mESCs (Figure 4D).
Subsequently, these two cell lines were treated, respectively,
with inhibitors against Fgfr (PD073074), Mek (PD0325901), Jnk
(SP600125), and phosphatidylinositol 3-kinase (LY294002) for
48 hr. It was found that PD073074 and PD0325901 specifically
inhibited Gata6 expression (Figure 4E) and induced Nanog
expression in both cell lines (Figure S5A). No significant changes
of the expression level of T and Fgf5were observed (Figures S5B
and S5C). In order to confirm that the Erk pathway is specifically
required for endoderm differentiation in our ESC line, we used
a small hairpin RNA (shRNA) construct against Erk1 gene to
knockdown its expression (Figure S5D). Effective suppression
of endoderm-related gene expression was observed in the Erk
knockdown mESCs (Figure 4F).
Sodium orthovanadate (Na3VO4), a tyrosine phosphatase in-
hibitor, has been shown to be able to induceWTmESCs to differ-
entiate into endoderm through the Erk pathway. Indeed, after
treatment with 20 mM Na3VO4 for 24 hr, the level of p-Erk in
Setd2/ mESCs was induced to a level similar to that in WT
ESCs (Figure S5E). Moreover, Gata6 could be significantly
induced in both cell lines (Figure 4G). On the other hand, in
previous reports, no such induction effects existed in Grb2/
mESCs and c-Myc-overexpressed mESCs (Hamazaki et al.,
2006; Smith et al., 2010), which is in agreement with the concept
that Erk is located downstream to Grb2 in signal transduction. It
has been known that the Erk pathway can also be activated by
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Figure 3. Setd2 Regulates Visceral Endoderm Development In Vivo
(A) Teratoma development in mice. WT (left) and Setd2/ (right) mESCs (5 3 106) were subcutaneous inoculated into NOD-SCID mice on both side. Dotted
circles indicate the areas occupied by tumors.
(B) Morphology of teratomas derived from WT (top) and Setd2/ (bottom) mESCs.
(C) Weights of teratomas obtained after injection of WT (left; n = 9) and Setd2/ (right; n = 8) mESCs. Data are presented as means ± SEM; *p < 0.05.
(D) Histology of WT (top) and Setd2/ (bottom) teratoma. Left: nervous tissue (ectoderm); middle: muscle and adipocyte tissue (mesoderm); right: intestinal
epithelium tissue (endoderm). The scale bar represents 50 mm. Black dotted circles indicate intestinal epithelium vessel.
(E) Light microscopy (left) and electron microscopy images (right) of E10 WT (top) and Setd2/ (bottom) yolk sac. Arrows and asterisks indicate visceral
endoderm of yolk sac. The scale bar represents 1 mm.
(F) DAVID functional annotation analysis of upregulated (left) and downregulated (right) genes between E10 WT and Setd2/ yolk sac.
(G) Real-time PCR validation of differentially expressed cytoskeletal binding genes between E10 WT and Setd2/ yolk sac. Means ± SD from at least triplicate
measurements are shown. *p < 0.05; **p < 0.01; ***p < 0.001.
(H) F-actin immunofluorescence staining of E10 WT (left) and Setd2/ (right) yolk sac. The scale bar represents 10 mm.
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Figure 4. Setd2 Regulates mESC Endoderm Differentiation through MAPK Signaling Pathway
(A) 2D plots of total RNA-seq genes (17,827) in WT and Setd2/ mESCs. Up- and downregulated genes with fold changeR2.0 are highlighted.
(B) KEGG pathway analysis of downregulated genes in Setd2/ mESCs compared with WT.
(C) Left: a schematic diagram of theMAPK signaling pathway, showing themajor regulators and their inhibitors written in circles and squares, respectively. Right:
immunoblotting analysis of the MAPK signaling pathway in WT and Setd2/ mESCs with antibodies indicated on the right.
(D) Immunoblotting analysis of Erk phosphorylation inWTandSetd2/mESCs thatwere serumstarved and treatedwith 20 ng/ml Fgf2 andFgf4 for 10 and20min.
(E) Real-time PCR analysis of Gata6 expression in WT and Setd2/ mESCs treated with different inhibitors indicated on the right.
(F)Real-timePCRanalysisofendoderm-lineage-relatedgenes inWTmESCstreatedwithmouseErk1shRNA.ScrambledshRNA(NC)wasusedasanegativecontrol.
(G) Real-time PCR analysis of Gata6 expression (right) in WT and Setd2/ mESCs treated with DMSO and Na3VO4.
(H) Real-time PCR analysis of endoderm-lineage-related gene expression in Setd2/ mESCs transfected with N-RasG12D.
All qPCR data are presented as means ± SD of triplicate measurements. *p < 0.05; **p < 0.01; ***p < 0.001.
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N-RasG12D (Cuiffo and Ren, 2010). As expected, the expression
level of p-Erk increased dramatically (Figure S5F), accompanied
by upregulation of Gata6, Sox7, and Dab2 in N-RasG12D-
transfected Setd2/ ESCs (Figure 4H). All these results suggest
that blockage of the Erk signaling pathway by Setd2 deficiency
should be the major cause for endoderm defects.
Fgfr3 Transcriptional Initiation Is Impaired in
Setd2/ mESCs
Having shown that the Mek-Erk pathway is required for the
endoderm development, whereas Fgf2 and Fgf4 fail to activate
Erk in Setd2/ ESCs, we set to address the mechanism by
which Setd2 regulates this pathway. Comprehensive analysis
of RNA-seq data and real-time PCR assay revealed that Fgfr3
and Fgfr4 were downregulated in Setd2/ ESCs (Figure 5A).
The specific expression pattern of Fgfr3 during endoderm differ-
entiation (Chen et al., 2000) raised the possibility that aberrant
expression of Fgfr3 could play a role in the endoderm defects
caused by Setd2 deficiency. Indeed, enforced expression of hu-
man FGFR3 led to upregulation of endoderm-related genes in
Setd2/ mESCs (Figure 5B), suggesting that Setd2 regulates
endoderm development through Fgfr3. We then moved to
address how Setd2 modulates the expression of Fgfr3. It has
been reported that Set2 could regulate transcriptional elongation
in yeast (Li et al., 2002). We thus analyzed the intron-containing
nascent transcripts to determine the potential defects of tran-
scription elongation in Setd2/ mESCs by real-time PCR with
primers covering different intronic regions of Fgfr3 gene. The
expression of almost all of the examined intronic regions, from
N-terminal to C-terminal region of Fgfr3, was declined at the
similar rate in Setd2/ mESCs (Figure 5C), indicating that there
should be no major elongation defects to this gene. Further
investigation showed that all isoforms ofmature Fgfr3 transcripts
were downregulated (Figure 5D), suggesting that transcriptional
initiation defects might exist in Fgfr3. An RNA pol II chromatin
immunoprecipitation (ChIP) assay was performed to test this
hypothesis. As expected, the binding affinity of RNA pol II was
reduced significantly at 0.2 kb upstream from the transcrip-
tional start site and intron1 (200 bp downstream from the tran-
scriptional start site) of Fgfr3 in Setd2/ mESCs (Figure 5E).
To address if Fgfr3 transcription could be specifically regulated
by Setd2, we transfected human SETD2 fragment (503–2,564
aa) into Setd2/ mESCs and examined the Fgfr3 expression.
Indeed, SETD2 upregulated the mRNA level of Fgfr3 (Figure 5F).
We then cloned the 2 kb upstream promoter sequence of Fgfr3
into a PGL3-basic luciferase vector and transfected it into WT
and Setd2/ mESCs. Dual-luciferase reporter assays showed
that the activity of this region was much lower in mutant mESCs
(Figure 5G). And these transcription defects could be rescued by
enforced expression of SETD2 (Figure 5H). These data indicate
that the transcriptional initiation of Fgfr3 is regulated by Setd2.
Setd2-Mediated H3K36me3 Modification in Distal
Promoter Region Regulates Fgfr3 Gene Transcription
We next analyzed how Setd2 influenced the transcriptional
initiation of Fgfr3. In view of the roles of H3K4 and H3K27 trime-
thylation in the regulation of gene transcriptional activation and
inhibition, ChIP-PCR assays were performed to clarify whether
H3K4 and H3K27 trimethylation were involved in transcriptional
initiation of Fgfr3 in Setd2/ mESCs. In fact, no obvious differ-
ences appeared when the results in Setd2/ mESCs were
compared with those of WT mESCs (Figure S6A). In addition,
Setd2 was not associated with the DNA methylation pattern
of Fgfr3 CpG islands (Figure S6B). Ferrari et al. (2014) recently
showed that knocking down of Setd2 could facilitate the
conversion from H3K27me1 to H3K27me2, which may be
associated with gene transcriptional regulation, affecting the
expression level of Fgfr3 and other endoderm-related genes.
To test this notion, we performed H3K27me1 and H3K27me2
ChIP assays on WT and Setd2/ mESCs. The ratios of these
two modifications on endoderm-related genes did not exhibit
significant differences between WT and Setd2/ mESCs
(Figure S6C), suggesting that the conversion from H3K27me1
to H3K27me2 is not involved in regulation of Fgfr3 expression
by Setd2.
To address the possibility of other epigenetic abnormalities
in Setd2/ mESCs, histone modification states of WT and
Setd2/ mESCs cell lines were determined by western blot,
and the results showed that H3K36me3, but not other histone
modification, was dramatically downregulated in Setd2/
mESCs (Figure S6D). The distribution of H3K36me3 on the whole
genome was thus analyzed based on published ChIP-seq data
(Mikkelsen et al., 2007). About 18% of H3K36me3 peaks were
found to distribute on upstream enhancer region (Figure 6A),
suggesting that H3K36me3 could serve as a landmark for an
enhanced regulation of transcriptional machinery. Our ChIP-
quantitative PCR (qPCR) results demonstrated that H3K36me3
mainly distributed in the coding region of Fgfr3 in WT mESCs,
whereas the modification level in Fgfr3 proximal promoters
(0.2 kb) and N- terminal region (intron1 and intron2) was
very low, similar to that in Setd2/ mESCs. However, the
H3K36me3 modification in its distal promoter region (0.5 kb,
1.5 kb, and 2 kb) was much more enriched and displayed
significant differences between WT and Setd2/ mESCs (Fig-
ure 6B). Subsequently, we performed aChIP assay of ectopically
expressed FLAG-tagged SETD2 with anti-FLAG in Setd2/
mESCs and observed a direct binding of SETD2 on Fgfr3 locus
(Figure S6E). These data indicate that Setd2 could regulate
Fgfr3 expression from the distal promoter/enhancer. Further-
more, Arc and Cd97, two other genes downregulated by Setd2
disruption, showed similar H3K36me3 distribution pattern in
mESCs (Figure 6C). Arc has also been known to be required for
endoderm development (Liu et al., 2000). In order to investigate
whether Setd2-dependent H3K36me3 could directly regulate
the Fgfr3 transcription, we tethered human SETD2 on Fgfr3
promoter region by using Gal4-upstream activating sequence
system. Luciferase reporter assay results showed that SETD2
fragment (503–2,564 aa) or Set region (1,418–1,714 aa) and
low-charge region (LCR) (2,198–2,564 aa) of SETD2 could effec-
tively activate Fgfr3 promoter in 293T cells andSetd2/mESCs.
To determine which domain plays a crucial role in Fgfr3 tran-
scription, we deleted the set or LCR region in SETD2 fragment,
respectively. As compared with the SETD2 fragment, 6set
activates the Fgfr3 promoter with a significantly less efficiency.
However, 6LCR displayed only a slightly lower transcriptional
activation effect than the SETD2 fragment did (Figure 6D). Taken
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Figure 5. Defect of Fgfr3 Transcriptional Initiation in Setd2/ mESCs
(A) Real-time PCR analysis of Fgfr3 and Fgfr4 expression level in WT and Setd2/ mESCs.
(B) Left: real-time PCR analysis of the expression level of endoderm-related genes in GFP- and FGFR3-overexpressed Setd2/ mESCs. Right: western blot
analysis of the protein expression level of FGFR3 in GFP- and FGFR3-overexpressed Setd2/ mESCs.
(C) Real-time PCR analysis of the expression level of Fgfr3 heterogeneous nuclear RNA by using indicated primer sets. Gapdh served as a control.
(D) Real-time PCR analysis of different Fgfr3-splicing isoforms in WT and Setd2/ mESCs.
(E) ChIP-qPCR analysis of RNA polymerase II binding to the Fgfr3 locus. Primer sets are indicated in the upper diagram. Groups without antibody were served as
negative control for ChIP assay.
(F) Real-time PCR analysis of Fgfr3 expression in Setd2/ mESCs transfected with human SETD2. GFP vector was used as a control for transfection.
(G) Luciferase assay to analyze Fgfr3 promoter activity in WT and Setd2/ mESCs.
(H) Coexpression with Setd2 in Setd2/ mESCs increases Fgfr3 promoter activity, as indicated by luciferase reporter assay.
Averages ± SD are from triplicate measurements. *p < 0.05; **p < 0.01; ***p < 0.001.
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Figure 6. H3K36me3 on Distal Promoter Is Essential for Fgfr3 Gene Transcription
(A) Distribution of H3K36me3-enriched regions relative to mouse genome. Top: schematic for seven counting categories. Bottom: pie chart for percentage
distribution of H3K36m3 tags in each category. Published H3K36me3 ChIP-seq data are from Mikkelsen et al. (2007).
(legend continued on next page)
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together, these data show that Setd2-dependent H3K36me3
could directly regulate Fgfr3 transcriptional initiation in mESCs.
DISCUSSION
Recent studies of histone modifications in ESCs have focused
on the function of H3K4me3, H3K27me3, H3K9me2/H3K9me3,
and histone acetylation in self-renewal and lineage progenitor
cell differentiation (Ang et al., 2011; Li et al., 2012; Loh et al.,
2007; Peng et al., 2009). Unlike these modifications that mostly
occur at the promoter region, H3K36me3 is known to mainly
distribute in gene body regions in mESCs and other mammalian
cells (Mikkelsen et al., 2007). For this reason, researches on
H3K36me3 have been largely concentrated on these regions. It
has also been shown that H3K36me3 can regulate transcrip-
tional elongation through interacting with RNA pol II (Li et al.,
2002), whereas H3K36me3 can suppress histone exchange
to maintain the accuracy of transcription by RNA pol II in body
regions after elongation (Venkatesh et al., 2012). Moreover,
H3K36me3 has also been recognized as a marker for alternative
splicing (Luco et al., 2010). However, no evidence of direct
link between H3K36me3 and transcriptional initiation has yet
been revealed. The impact of H3K36me3 on the actual cellular
functions such as ESC self-renewal or lineage differentiation,
as well as the underlying molecular mechanism, was largely
unknown.
In this study, we found that knockout of Setd2 could specif-
ically reduce the basal expression level of many primitive endo-
derm-related genes in mESCs (Figure 1F), thereby blocking
subsequent differentiation of EBs endoderm lineage (Figures
1C, S2A, and S2B), but had no effects on mESCs self-renewal
and other lineage differentiation (Figures S1 and S2C–S2H).
Further studies showed that the Erk pathway was significantly
impaired in Setd2/ mESCs (Figures 4C and 4D). Erk inhibitor
or activator could suppress or stimulate the expression of endo-
derm-related genes in both Setd2/ and WT mESCs (Figures
4E–4H). It has been reported that this pathway can trigger
transition of ESCs from self-renewal to endoderm lineage
commitment (Kunath et al., 2007). In mESCs, Fgf receptor tyro-
sine kinase can activate the Erk pathway and specify the primi-
tive endoderm development in vivo (Frankenberg et al., 2011),
whereas inhibiting this pathway allows the maintenance of ESC
self-renewal ability (Ying et al., 2008). Our RNA-seq data com-
bined with real-time PCR revealed that Fgfr3, which should be
specifically expressed in endoderm cells during differentiation
(Chen et al., 2000), was downregulated in Setd2/ mESCs
(Figure 5A). Enforced expression of this gene could effectively
rescue the expression of primitive endoderm-related genes in
Setd2/ mESCs (Figure 5B).
We also found that, different from the role of H3K36me3
in transcriptional elongation, intragenic transcriptional initiation,
and alternative splicing, the Fgfr3 transcriptional initiation was
defected inSetd2/mESCs (Figures 5C–5G). Although the non-
coding region of exon1 of Fgfr3 exhibited alternative 50 splicing
site defect (A5SS; Figure S4D), it hardly constituted a convincing
mechanism to explain the low expression level of Fgfr3 observed
in Setd2/ mESCs. Histone H3K4me3, H3K27me3, and DNA
methylation are the major mechanisms for regulation of gene-
transcriptional initiation. Nevertheless, no differences in these
regulatory mechanisms were detectable in Fgfr3 promotor
region between WT and Setd2/ mESCs (Figures S6A and
S6B). When the histone modification state was checked, only
H3K36me3 was found to be downregulated in Setd2/ mESCs
(Figure S6D). The results suggest that H3K36me3 might directly
regulate the initiation of gene expression in mESCs. Overall
speaking, despite the main distribution of H3K36me3 in body re-
gions of actively transcribed genes, many H3K36me3 tags were
found in distal promoter or upstream enhancer regions, whereas
only scarce distribution of these tags existed in proximal pro-
moter (Figure 6A). It is worth noting that this distal promoter dis-
tribution pattern of H3K36me3was observed in Fgfr3 (Figure 6B).
Moreover, artificial targeting of Set domain or SETD2 fragment
(503–2,564 aa) to Fgfr3 promoter region led to its transcriptional
activation (Figure 6D). Notably, some other genes downregu-
lated by Setd2 deficiency, such as Arc and Cd97, also displayed
this distribution pattern of H3K36me3 (Figure 6C). Hence, we
put forward amodel that Setd2 influencesmESCs endoderm dif-
ferentiation through regulating transcriptional initiation of Fgfr3,
as shown in Figure 6E.
Recently, several groups have revealed that human SETD2
was frequently mutated or downregulated in some types of can-
cer through whole-genome sequencing, such as cRCC (Cancer
Genome Atlas Research Network, 2013; Dalgliesh et al., 2010;
Duns et al., 2010) and acute leukemia (Mar et al., 2014; Zhu
et al., 2014). In one report, H3K36me3 could interact with
hMSH6 PWWP domain of hMutSa, which is important for DNA
mismatch repair and maintains genome stability during replica-
tion, and RNAi knockdown of SETD2 could elevate spontaneous
(B) ChIP-qPCR analysis of H3K36me3 enrichment on Fgfr3 locus in WT and Setd2/ ESCs. Primer sets are indicated on the top. Groups without antibody were
served as negative control for ChIP assay.
(C) Real-time PCR analysis of gene expression (left) and ChIP-qPCR analysis of H3K36me3 enrichment (right) of two other genes, Arc and Cd97. Groups without
antibody were served as negative control for ChIP assay.
(D) Luciferase reporter assay of the role of Setd2 on Fgfr3 promoter activation. a: schematic representation of Gal4-tagged Setd2 constructs. b and c: induction of
Gal4-Fgfr3 promoter-driven luciferase gene transcription by Gal4-tagged Setd2 in HEK293T (b) and Setd2/ mESCs (c).
Averages ± SD are from triplicate measurements. *p < 0.05; **p < 0.01; ***p < 0.001.
(E) Schematic representing of the role of Setd2 in endoderm differentiation of mESC. Left: in normal mESCs, the upstream enhancer region of Fgfr3 can be
combined by unknown regulatory factors, which may recruit Setd2, and then Setd2 catalyzes H3K36me3 of this region. This marker can be recognized by some
cofactors or readers and then help to form transcription initiation complex, which can regulate Fgfr3 expression. Fgfs stimulate Mek-Erk signaling cascade
through Fgfr3 and keep endoderm-related genes on a basal expression level in mESCs, which is the prerequisite for normal endoderm differentiation after LIF
withdrawal. Right: in Setd2/ mESCs, Fgfr3 loses H3K36me3 in the upstream enhancer region and its expression is decreased, which blocks the Mek-Erk
signaling cascade and specifically influences basal expression level of the endoderm-related genes in mESCs, thus impairing subsequent endoderm differ-
entiation after LIF withdrawal.
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mutation frequency andmicrosatellite instability in tumor cell line
(Li et al., 2013). These findings may provide an explanation for
the mechanism of tumor formation. However, deregulation of
gene expression in these cancers can hardly be ascribed to
spontaneous mutation caused by SETD2 disruption. Our finding
that H3K36me3 distal promoter distribution plays a role in endo-
derm differentiation may help to understand the role of SETD2 in
tumorigenesis.
EXPERIMENTAL PROCEDURES
Detailed procedures are described in the Supplemental Experimental
Procedures.
ESC Culture and Embryonic Body Formation
WT and Setd2/ ESCs were cultured on feeder cells in standard ES
medium (Dulbecco’s modified Eagle’s medium supplemented with 15%
fetal bovine serum [GIBCO], 1 3 nonessential amino acids, 2 mM L-gluta-
mine, 100 U/ml penicillin, 100 mg/ml streptomycin, 0.1 mM b-mercaptoe-
thanol, and 1,000 U/ml LIF [ESGRO; Millipore]). Trypsinized ESCs were
transferred on gelatin-coated cell culture dishes for half an hour to remove
feeder cells, and supernatant ESCs were collected, plated onto Petri dishes,
and cultured in suspension without LIF for 3, 6, and 9 days. For attached
cultures, day 3 suspension-cultured EBs were transferred on gelatin-coated
cover glasses for 3 days and then stained with wrights and Giemsas. AP
activity was monitored using the commercial Alkaline Phosphatase Detec-
tion kit (Vector Laboratories; SK-5400) according to the manufacturer’s
instructions.
Teratoma Formation
5 3 106 WT and Setd2/ ESCs were injected subcutaneously into the same
NOD-SCID mice at different side. Four weeks later, mice were euthanized
and tumors were removed and fixed in formalin for several days and then
subsequently imbedded in paraffin, sectioned, and stained with hematoxylin
and eosin for histological analysis. Mice were used according to animal care
standards, and all protocols were approved by the Committee of Animal
Use for Research at Shanghai Jiao Tong University School of Medicine
(China).
mRNA-Seq and qRT-PCR
For RNA-seq, about 20 ng of Poly (A) RNA was purified from total RNA and
then converted to double-stranded cDNA, and cDNA samples were
sequenced using standard Solexa protocols. The sequencing reads were
mapped to mouse genome (mm9) using TopHat (version 1.0.13). Avadis
NGS (version 1.3) was used to calculate reads per kb per million reads
(RPKM) values and find genes or different spliced genes. Differential genes
were called at 2-fold changes using RPKM. GO and KEGG analyses were per-
formed with DAVID (http://david.abcc.ncifcrf.gov/). For qRT-PCR, total RNA
was reverse transcripted with the High Capacity cDNA Reverse Transcription
Kit (Applied Biosystems). Real-time PCR was performed with the SYBR Pre-
mix Ex Taq (TAKARA). The relative gene-expression levels were presented
by 2^ DDCt, and Gapdh was used as internal control. Primers will be provided
upon request.
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RNA-seq data have been deposited to the NCBI Gene Expression Omnibus
under accession number GSE54932.
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